HWAM
BLUE

Hennion & Walsh Asset Management’s bluebird bio BLUE Stock Holding History

Hennion & Walsh Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,433
Closed -$148K – 821
2023
Q3 		$148K Sell
2,433
-481
-17% -$33.8K 0.01% 765
2023
Q2 		$192K Sell
2,914
-2,102
-42% -$154K 0.01% 755
2023
Q1 		$319K Sell
5,016
-141
-3% -$16.1K 0.02% 625
2022
Q4 		$714K Buy
5,157
+514
+11% +$72.4K 0.04% 408
2022
Q3 		$588K Sell
4,643
-118
-2% -$13.3K 0.04% 449
2022
Q2 		$394K Buy
4,761
+242
+5% +$18.8K 0.02% 543
2022
Q1 		$438K Buy
4,519
+1,042
+30% +$138K 0.02% 543
2021
Q4 		$695K Buy
3,477
+665
+24% +$157K 0.03% 455
2021
Q3 		$696K Buy
2,812
+963
+52% +$275K 0.04% 438
2021
Q2 		$766K Buy
1,849
+1,330
+256% +$527K 0.04% 422
2021
Q1 		$203K Buy
+519
New +$256K 0.01% 668

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Hennion & Walsh Asset Management's BLUE Position: Q4 2023 in Review

Hennion & Walsh Asset Management sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 2,433 shares — an estimated $148K sold.

Hennion & Walsh Asset Management first reported a position in BLUE in Q1 2021 and held it in 11 quarters. The position peaked at $766K in Q2 2021. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Hennion & Walsh Asset Management reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 2,433 bluebird bio shares in Q4 2023, an estimated $148K.
  • Hennion & Walsh Asset Management first reported a position in bluebird bio in Q1 2021 and held it in 11 quarters.
  • Hennion & Walsh Asset Management's bluebird bio position peaked at $766K in Q2 2021.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.